Related Experiment Videos

[Fibrinolytic and thrombolytic properties of the drug morikrase]

Voprosy Meditsinskoi Khimii
|May 1, 1994
PubMed

Insights

Morikrase, a king crab proteinase complex, demonstrates significant fibrinolytic and thrombolytic activity. This preparation effectively dissolves blood clots and maintains stability, showing potential for therapeutic applications.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Marine Biology

Context:

  • Investigating novel therapeutic agents from natural sources.
  • Assessing the properties of proteinases from king crab (Paralithodes camtschatica).

Purpose:

  • To evaluate the fibrinolytic and thrombolytic potential of morikrase.
  • To determine the stability and in vivo/in vitro efficacy of morikrase.

Summary:

  • Morikrase exhibits high fibrinolytic activity on fibrin plates and dose-dependent activation.
  • The preparation demonstrated thrombolytic effects on preformed thrombi in vitro and in vivo (rats).
  • Morikrase showed stability during long-term storage and induced a two-phase alteration in the fibrinolytic system with moderate hypocoagulation post-administration.

Impact:

  • Morikrase shows promise as a novel therapeutic agent for thrombotic disorders.
  • The study highlights the potential of marine-derived enzymes in pharmaceutical development.
  • Findings contribute to understanding the mechanisms of fibrinolysis and thrombolysis.

Related Concept Videos